Haemonetics (HAE) News Today $85.60 -1.88 (-2.15%) (As of 11:46 AM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Atom Investors LP Invests $1.57 Million in Haemonetics Co. (NYSE:HAE)Atom Investors LP purchased a new stake in shares of Haemonetics Co. (NYSE:HAE - Free Report) during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 19,545 shares of the medical instruments supplier's stock, valued atDecember 3 at 5:58 AM | marketbeat.comBridgewater Associates LP Sells 35,747 Shares of Haemonetics Co. (NYSE:HAE)Bridgewater Associates LP lowered its stake in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 82.0% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 7,826 shares of the medical instruments supplier's stDecember 3 at 4:02 AM | marketbeat.comHaemonetics To Sell Its Whole Blood Assets To GVS - Quick FactsDecember 3 at 3:09 AM | markets.businessinsider.comHaemonetics Announces Sale of Whole Blood Assets to GVS, S.p.ADecember 3 at 2:19 AM | gurufocus.comHaemonetics Announces Sale of Whole Blood Assets to GVS, S.p.ADecember 3 at 1:16 AM | prnewswire.comQ3 EPS Estimates for Haemonetics Decreased by Zacks ResearchDecember 2 at 1:52 AM | americanbankingnews.comZacks Research Decreases Earnings Estimates for HaemoneticsHaemonetics Co. (NYSE:HAE - Free Report) - Investment analysts at Zacks Research cut their Q3 2025 EPS estimates for shares of Haemonetics in a report issued on Wednesday, November 27th. Zacks Research analyst R. Department now anticipates that the medical instruments supplier will post earningsDecember 2 at 1:50 AM | marketbeat.comIsthmus Partners LLC Sells 8,326 Shares of Haemonetics Co. (NYSE:HAE)Isthmus Partners LLC reduced its holdings in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 17.3% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 39,770 shares of the medicalNovember 29, 2024 | marketbeat.comCitigroup Inc. Has $15.57 Million Stake in Haemonetics Co. (NYSE:HAE)Citigroup Inc. trimmed its stake in Haemonetics Co. (NYSE:HAE - Free Report) by 96.7% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 193,658 shares of the medical instruments supplier's stock after selling 5,678,717November 28, 2024 | marketbeat.comHaemonetics Co. (NYSE:HAE) Shares Acquired by Loomis Sayles & Co. L PLoomis Sayles & Co. L P increased its stake in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 8.1% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 163,856 shares of the medical instruments supplierNovember 27, 2024 | marketbeat.comHaemonetics Co. (NYSE:HAE) Receives Average Rating of "Moderate Buy" from BrokeragesShares of Haemonetics Co. (NYSE:HAE - Get Free Report) have been given an average recommendation of "Moderate Buy" by the eight analysts that are presently covering the stock, MarketBeat.com reports. Two analysts have rated the stock with a hold recommendation, five have issued a buy recommendatioNovember 26, 2024 | marketbeat.comIntech Investment Management LLC Acquires 8,626 Shares of Haemonetics Co. (NYSE:HAE)Intech Investment Management LLC grew its holdings in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 62.9% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 22,329 shares of the medical instrumNovember 26, 2024 | marketbeat.comHaemonetics Co. (NYSE:HAE) Shares Sold by Eagle Asset Management Inc.Eagle Asset Management Inc. reduced its stake in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 54.1% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 100,565 shares of the medical instruments supplier's stock after selling 118,636 shares during the peNovember 25, 2024 | marketbeat.comWestfield Capital Management Co. LP Has $66.21 Million Position in Haemonetics Co. (NYSE:HAE)Westfield Capital Management Co. LP raised its holdings in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 10.9% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 823,663 shares of the medical instruments supplier's sNovember 24, 2024 | marketbeat.comAdvancements and market trends in arteriotomy closure devicesNovember 22, 2024 | yahoo.comHaemonetics Co. (NYSE:HAE) Shares Bought by Connor Clark & Lunn Investment Management Ltd.Connor Clark & Lunn Investment Management Ltd. increased its position in Haemonetics Co. (NYSE:HAE - Free Report) by 439.9% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 220,453 shares of the medical instruments supplier's stock after purchasing an additionalNovember 21, 2024 | marketbeat.comGlobal Alpha Capital Management Ltd. Makes New Investment in Haemonetics Co. (NYSE:HAE)Global Alpha Capital Management Ltd. purchased a new position in shares of Haemonetics Co. (NYSE:HAE - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 10,025 shares of the medicaNovember 20, 2024 | marketbeat.comThrivent Financial for Lutherans Has $88.43 Million Position in Haemonetics Co. (NYSE:HAE)Thrivent Financial for Lutherans boosted its holdings in Haemonetics Co. (NYSE:HAE - Free Report) by 29.5% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,100,183 shares of the medical instruments supplNovember 18, 2024 | marketbeat.comPrincipal Financial Group Inc. Decreases Stake in Haemonetics Co. (NYSE:HAE)Principal Financial Group Inc. lessened its holdings in Haemonetics Co. (NYSE:HAE - Free Report) by 19.4% during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 155,259 shares of the medical instruments supplier's stock afterNovember 17, 2024 | marketbeat.comStrategic Investment and Growth Potential Drive Buy Rating for HaemoneticsNovember 16, 2024 | markets.businessinsider.comMizuho Markets Americas LLC Sells 15,116 Shares of Haemonetics Co. (NYSE:HAE)Mizuho Markets Americas LLC trimmed its stake in Haemonetics Co. (NYSE:HAE - Free Report) by 4.2% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 348,478 shares of the medical instruments supplier's stock after sellingNovember 16, 2024 | marketbeat.comHaemonetics (NYSE:HAE) Earns "Buy" Rating from Needham & Company LLCNeedham & Company LLC reiterated a "buy" rating and set a $112.00 price objective on shares of Haemonetics in a research report on Friday.November 15, 2024 | marketbeat.comHaemonetics Co. (NYSE:HAE) is Royce & Associates LP's 6th Largest PositionRoyce & Associates LP lifted its holdings in Haemonetics Co. (NYSE:HAE - Free Report) by 2.6% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,210,546 shares of the medical instruments supplier's stock afterNovember 15, 2024 | marketbeat.comAigen Investment Management LP Makes New Investment in Haemonetics Co. (NYSE:HAE)Aigen Investment Management LP acquired a new position in Haemonetics Co. (NYSE:HAE - Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 5,959 shares of the medical instruments supplier'November 15, 2024 | marketbeat.comHaemonetics management to meet virtually with BTIGNovember 14, 2024 | markets.businessinsider.comHaemonetics to close California facility, lay off 75 peopleNovember 14, 2024 | finance.yahoo.comRaymond James Upgrades Haemonetics (HAE)November 10, 2024 | msn.comHaemonetics: Strong Financial Performance and Promising Outlook Justify Buy RatingNovember 10, 2024 | markets.businessinsider.comHaemonetics upgraded to strong buy by Raymond JamesNovember 10, 2024 | msn.comBarrington Research Reaffirms Outperform Rating for Haemonetics (NYSE:HAE)Barrington Research reiterated an "outperform" rating and set a $108.00 target price on shares of Haemonetics in a research note on Friday.November 8, 2024 | marketbeat.comHaemonetics (NYSE:HAE) Issues Earnings Results, Beats Estimates By $0.03 EPSHaemonetics (NYSE:HAE - Get Free Report) announced its quarterly earnings results on Thursday. The medical instruments supplier reported $1.12 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.09 by $0.03. Haemonetics had a net margin of 8.61% and a return on equity of 21.86%. The firm had revenue of $345.50 million for the quarter, compared to the consensus estimate of $342.57 million. During the same period in the prior year, the firm posted $0.99 earnings per share. The company's revenue for the quarter was up 8.6% on a year-over-year basis.November 8, 2024 | marketbeat.comDeep Dive Into Haemonetics Stock: Analyst Perspectives (7 Ratings)November 8, 2024 | benzinga.comHaemonetics’ Strong Financial Performance and Growth Potential Drive Buy Rating with $125 Price TargetNovember 8, 2024 | markets.businessinsider.comRaymond James Upgrades Haemonetics (NYSE:HAE) to "Strong-Buy"Raymond James raised Haemonetics from an "outperform" rating to a "strong-buy" rating and set a $120.00 price objective for the company in a research report on Friday.November 8, 2024 | marketbeat.comHaemonetics reports Q2 adjusted EPS $1.12, consensus $1.07November 8, 2024 | markets.businessinsider.comHaemonetics Earns Buy Rating for Strong Q2 Performance and Margin ImprovementsNovember 8, 2024 | markets.businessinsider.comHaemonetics (NYSE:HAE) Shares Gap Up - Still a Buy?Haemonetics (NYSE:HAE) Shares Gap Up - Time to Buy?November 7, 2024 | marketbeat.comHaemonetics (NYSE:HAE) Updates FY25 Earnings GuidanceHaemonetics (NYSE:HAE) updated its FY25 earnings guidance. The company provided EPS guidance of $4.45-4.75 for the period, compared to the consensus estimate of $4.59. The company also issued revenue guidance of $1.37-1.41 billionillion, compared to the consensus estimate of $1.40 billionillion.November 7, 2024 | marketbeat.comHaemonetics 2nd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations WebsiteNovember 7, 2024 | prnewswire.comIonis Pharmaceuticals Beats on RevenueNovember 6, 2024 | fool.comHaemonetics Corp (HAE) Q2 2025 Earnings Report Preview: What To ExpectNovember 6, 2024 | finance.yahoo.comData Underwhelms - Intellia's Cash, Data And Competition Are A Challenging StoryNovember 5, 2024 | seekingalpha.comHarbor Capital Advisors Inc. Acquires 30,389 Shares of Haemonetics Co. (NYSE:HAE)Harbor Capital Advisors Inc. lifted its stake in Haemonetics Co. (NYSE:HAE - Free Report) by 117.9% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 56,164 shares of the medical instruments supplier's stock after acNovember 4, 2024 | marketbeat.comF M Investments LLC Acquires New Stake in Haemonetics Co. (NYSE:HAE)F M Investments LLC acquired a new stake in shares of Haemonetics Co. (NYSE:HAE - Free Report) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 102,472 shares of the medical instruments sNovember 3, 2024 | marketbeat.comAssenagon Asset Management S.A. Reduces Holdings in Haemonetics Co. (NYSE:HAE)Assenagon Asset Management S.A. trimmed its stake in Haemonetics Co. (NYSE:HAE - Free Report) by 75.2% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 15,223 shares of the medical instruments supplier's stock afterNovember 2, 2024 | marketbeat.comHaemonetics Co. (NYSE:HAE) Receives Consensus Recommendation of "Moderate Buy" from AnalystsShares of Haemonetics Co. (NYSE:HAE - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the seven ratings firms that are currently covering the company, Marketbeat.com reports. Two research analysts have rated the stock with a hold rating and five have assigned a buy raNovember 1, 2024 | marketbeat.comHaemonetics (HAE) Set to Announce Quarterly Earnings on ThursdayHaemonetics (NYSE:HAE) will be releasing earnings before the market opens on Thursday, November 7, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=633040)October 31, 2024 | marketbeat.comBoston Trust Walden Corp Purchases 98,019 Shares of Haemonetics Co. (NYSE:HAE)Boston Trust Walden Corp raised its stake in Haemonetics Co. (NYSE:HAE - Free Report) by 13.8% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 809,608 shares of the medical instruments supplier's stock after acquiring anOctober 26, 2024 | marketbeat.comIntellia Therapeutics Advances with Promising Phase 2 ResultsOctober 25, 2024 | markets.businessinsider.comIntellia Therapeutics: Promising Phase 2 Results and Growth Potential Justify Buy RatingOctober 25, 2024 | markets.businessinsider.com Get Haemonetics News Delivered to You Automatically Sign up to receive the latest news and ratings for HAE and its competitors with MarketBeat's FREE daily newsletter. Email Address The indicator behind Nvidia’s rally has a new prospect (Ad)Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run… All you have to do is follow this link here HAE Media Mentions By Week HAE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HAE News Sentiment▼1.080.87▲Average Medical News Sentiment HAE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HAE Articles This Week▼136▲HAE Articles Average Week Get Haemonetics News Delivered to You Automatically Sign up to receive the latest news and ratings for HAE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Align Technology News Merit Medical Systems News ICU Medical News DENTSPLY SIRONA News Neogen News QuidelOrtho News STAAR Surgical News Cerus News OraSure Technologies News Anika Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:HAE) was last updated on 12/3/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...Chaikin Analytics | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Haemonetics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Haemonetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HAE Stock Alerts